CD4 and neoplasm: In the immune microenvironment of HCC patients, cells including CD4+/CD8+ T cells, dendritic cells (DCs), and natural killer (NK) cells can promote immune response and exert antitumor effects, which contributes to effective immunological surveillance and mediates residual tumor cell eradication after radical surgery [5].